CATest

CAT for Healthcare Professionals

click here to print this page

How does the CAT work?

The CAT is short and simple, and should take only a few minutes to complete.

The CAT is a short and simple assessment test, which has been developed to be self-administered by patients.

The CAT can be used in an ongoing manner. Comparing consecutive CAT scores for a patient will provide valuable information for the long-term follow-up of patients.

How is the CAT administered?

The CAT questionnaire contains eight items. Patients read the two statements for each item, which describe the best and worst scenario, and decide where on the scale (0-5) they fit. Scores for each of the 8 items are summed to give an overall score (minimum 0, maximum 40). A higher score indicates a worse health status1.

The CAT is available as a paper-based test and as an interactive online tool. Use the ‘TAKE THE TEST’ icon at the bottom of the left-hand menu to find out more about these options.

 

Video Clip: Professor David Price discussing the benefit of the CAT.

This file is very large and so will take some time to download. For best results please right click this link, select 'Save Target as' to download the video to your C Drive, and then play the video.

 

Reference

  1. The COPD Assessment Test healthcare professional user guide: expert guidance on frequently asked questions. Jones PW, Jenkins C, Bauerle O (on behalf of the CAT Development Steering Group).

Page Last Updated: April 25, 2012

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.

Click Here to take the CATest
 
To print a paper version of CAT, click here. You will need Adobe Acrobat to read this file. Click here to download Adobe Acrobat.
 
If you are a healthcare professional, this guide will show you how to use the CAT in the best way.
GlaxoSmithKline

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.
Contact us
This website is intended for residents of the UK only.
Please read the legal notices and privacy notices.
Specific medical advice should always be sought from a qualified medical practitioner.
The development of the COPD Assessment Test was funded by GlaxoSmithKline.
GlaxoSmithKline UK Limited. Registered in England. Company No. 4310159.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
Code number: UK/RESP/0014/12 April 2012.